Indranil Bagchi

Indranil Bagchi is a distinguished pharmaceutical executive with a rich educational background and vast experience in pricing, reimbursement, health outcomes, and market access strategies within renowned pharmaceutical companies such as GlaxoSmithKline, Wyeth, Pfizer, and Novartis.

Throughout his career, Indranil Bagchi has garnered prestigious accolades, including the Wyeth President's Achieving Excellence Award in 2005, recognition in Pharmaceutical Executive magazine's annual list of Emerging Leaders in 2010, and the 'Outstanding 50 Asian Americans in Business' award by the Asian American Business Development Center in 2014.

His specialties encompass leadership, pricing & reimbursement, market access, health outcomes, and international public affairs and policy.

Indranil Bagchi holds an extensive educational background, including a Ph.D. in Pharmaceutical Socioeconomics from the University of Iowa, an M.S. in Pharmacy & Healthcare Administration from The University of Toledo, and a B.S. in Pharmacy from Jadavpur University.

Notable positions in Indranil Bagchi's career history include serving as the Senior Vice President and Head of Global Value & Access at Novartis, Vice President and Franchise Head of Global Value and Access at Novartis Oncology, Vice President and Head of Payer Insights and Access at Pfizer, and various leadership roles at Pfizer and GlaxoSmithKline.